Mimedx (MDXG) Other Non Operating Income (2014 - 2026)
Mimedx (MDXG) reported Other Non Operating Income of -$168000.0 for Q1 2026, down 15.86% on a YoY basis from -$199672.1 in Q1 2025, and up 9.68% sequentially from -$186000.0 in Q4 2025.
Mimedx (MDXG) Other Non Operating Income (2014 - 2026) Analysis & Trends
Mimedx (MDXG) has 12 years of Other Non Operating Income data on file, last reported at -$168000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 15.86% year-over-year to -$168000.0; the trailing twelve-month figure through Mar 2026 stood at -$581000.0 (up 4.91% YoY), and the FY2025 full-year result was -$558000.0, up 1.24% from the prior year.
- Other Non Operating Income climbed to -$168000.0 in Q1 2026, from -$186000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $16000.0 in Q4 2023 to a low of -$237000.0 in Q2 2024.
- A 5-year average of -$94214.3 and a median of -$100000.0 in 2024 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income surged 633.33% in 2023 and plunged 5050.0% in 2024, its largest moves.
- Tracing MDXG's Other Non Operating Income over 5 years: stood at -$3000.0 in 2022, then surged by 633.33% to $16000.0 in 2023, then tumbled by 1400.0% to -$208000.0 in 2024, then gained by 10.58% to -$186000.0 in 2025, then advanced by 9.68% to -$168000.0 in 2026.
- Business Quant data shows MDXG's Other Non Operating Income at -$168000.0 in Q1 2026, -$186000.0 in Q4 2025, and -$126000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -168,000.00 |
| Dec 31, 2025 | -186,000.00 |
| Sep 30, 2025 | -126,000.00 |
| Jun 30, 2025 | -101,000.00 |
| Mar 31, 2025 | -145,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -237,000.00 |
| Mar 31, 2024 | -99,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Jun 30, 2023 | -32,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Dec 31, 2021 | -20,000.00 |
| Jun 30, 2021 | -3,000.00 |
| Dec 31, 2020 | -8.20 Mn |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | -9,000.00 |
| Mar 31, 2020 | 6,000.00 |